| 11. |
- Sun, Ying, et al.
(författare)
-
Birth weight, ideal cardiovascular health metrics in adulthood, and incident cardiovascular disease
- 2024
-
Ingår i: Chinese Medical Journal. - : Wolters Kluwer. - 0366-6999. ; 137:10, s. 1160-1168
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Prenatal and postnatal factors may have joint effects on cardiovascular health, and we aimed to assess the joint association of birth weight and ideal cardiovascular health metrics (ICVHMs) prospectively in adulthood with incident cardiovascular disease (CVD).Methods: In the UK Biobank, 227,833 participants with data on ICVHM components and birth weight and without CVD at baseline were included. The ICVHMs included smoking, body mass index, physical activity, diet information, total cholesterol, blood pressure, and hemoglobin A1c. The Cox proportional hazards model was used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) in men and women.Results: Over a median follow-up period of 13.0 years (2,831,236 person-years), we documented 17,477 patients with incident CVD. Compared with participants with birth weights of 2.5–4.0 kg, the HRs (95% CIs) of CVD among those with low birth weights was 1.08 (1.00–1.16) in men and 1.23 (1.16–1.31) in women. The association between having a birth weight <2.5 kg and CVD risk in men was more prominent for those aged <50 years than for those of older age (P for interaction = 0.026). Lower birth weight and non-ideal cardiovascular health metrics were jointly related to an increased risk of CVD. Participants with birth weights <2.5 kg and ICVHMs score 0–1 had the highest risk of incident CVD (HR [95% CI]: 3.93 [3.01–5.13] in men; 4.24 [3.33–5.40] in women). The joint effect (HR [95% CI]: 1.36 [1.17–1.58]) could be decomposed into 24.7% (95% CI: 15.0%–34.4%) for a lower birth weight, 64.7% (95% CI: 56.7%–72.6%) for a lower ICVHM score, and 10.6% (95% CI: 2.7%–18.6%) for their additive interaction in women.Conclusions: Birth weight and ICVHMs were jointly related to CVD risk. Attaining a normal birth weight and ideal ICVHMs may reduce the risk of CVD, and a simultaneous improvement of both prenatal and postnatal factors could further prevent additional cases in women.
|
|
| 12. |
- Wang, W, et al.
(författare)
-
Stimulatory activity of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic receptors.
- 2000
-
Ingår i: Chinese medical journal. - 0366-6999. ; 113:10, s. 867-71
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: To study the activity of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic receptors on cAMP production and inward calcium currents (Ica) in guinea pig ventricular myocytes. A comparison was also made with those of a muscarinic receptor agonist. METHODS: cAMP content was determined by radioimmunoassay and the Ica in guinea pig single ventricular cells were recorded by the whole-cell patch clamp technique. RESULTS: Both the muscarinic receptor agonist, carbachol (Carb 10 mumol/L), and anti-peptide antibodies (Abs 100 nmol/L) could decrease basal cAMP levels (by 46.9% +/- 4.2% and 60.2% +/- 4.6%, respectively) and basal Ica. Both Carb (10 mumol/L) and Abs (100 nmol/L) could also inhibit the isoprenaline-induced (Iso 0.8 mumol/L) increases in cAMP production (from 108.2 +/- 7.0 to 88.4 +/- 7.2 pmol/mg.protein/min for Carb and 88.6 +/- 5.1 pmol/mg.protein/min for Abs, respectively) and the increases in Ica. The muscarinic receptor antagonist atropine (Atr) was able to prevent these effects of Carb and Abs. CONCLUSIONS: Anti-peptide antibodies against an epitope located in the second extracellular loop of human M2 muscarinic receptors, similar to muscarinic receptor agonist, could decrease the basal Ica and beta-receptor agonist stimulated increase of Ica by decreasing the basal and beta-receptor agonist stimulated increase of cAMP production, and therefore could have an effect on their target receptor. These results further suggest that autoimmunity may participate in the pathogenesis of human cardiomyopathy and the second extracellular loop of human M2 muscarinic receptor could be the main immunodominant region.
|
|
| 13. |
- Wang, Yufeng, et al.
(författare)
-
ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation : a report from the Chinese Atrial Fibrillation Registry
- 2023
-
Ingår i: Chinese Medical Journal. - : Lippincott Williams & Wilkins. - 0366-6999. ; 136:20, s. 2451-2458
-
Tidskriftsartikel (refereegranskat)abstract
- Background: The age, biomarkers, and clinical history (ABC)-atrial fibrillation (AF)-Stroke score have been proposed to refinestroke risk stratification, beyond what clinical risk scores such as the CHA2DS2-VASc score can offer. This study aimed toidentify risk factors associated with thromboembolism and evaluate the performance of the ABC-AF-Stroke score in predictingthromboembolism in non-anticoagulated AF patients following successful ablations.Methods: A total of 2692 patients who underwent successful ablations with discontinued anticoagulation after a 3-monthblanking period in the Chinese Atrial Fibrillation Registry (CAFR) between 2013 and 2019 were included. Cox regressionanalysis was conducted to present the association of risk factors with thromboembolism risk. The ABC-AF-Stroke score wasevaluated in terms of discrimination, including concordance index (C-index), net reclassification improvement (NRI) andintegrated discrimination improvement (IDI), clinical utilization by decision curve analysis (DCA), and calibration bycomparing the predicted risk with the observed annualized event rate.Results: After a median follow-up of 3.5 years, 64 patients experienced thromboembolism events. Age, prior history of stroke/transient ischemic attack (TIA), high-sensitivity cardiac troponin T (cTnT-hs), and N-terminal pro-B-type natriuretic peptide(NT-proBNP) were independently associated with thromboembolism risk. The ABC-AF-Stroke score performed statisticallysignificantly better than the CHA2DS2-VASc score in terms of C-index (0.67, 95% confidence interval [CI]: 0.59–0.74 vs. 0.60,95% CI: 0.52–0.67, P = 0.030) and reclassification capacity. The DCA implied that the ABC-AF-Stroke score could identifymore thromboembolism events without increasing the false positive rate compared to the CHA2DS2-VASc score. The calibrationcurve showed that the ABC-AF-Stroke score was well calibrated in this population.Conclusions: In this real-world study enrolling non-anticoagulated AF patients following successful ablations, age, prior historyof stroke/TIA, level of NT-proBNP, and cTnT-hs were independently associated with an increased risk of thromboembolism.The ABC-AF-Stroke score was well-calibrated and statistically significantly outperformed the CHA2DS2-VASc score inpredicting thromboembolism risk.
|
|
| 14. |
- Wang, Zhaohui, et al.
(författare)
-
Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
- 2003
-
Ingår i: Chinese medical journal. - 0366-6999. ; 116:4, s. 499-502
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: In order to explore the possible roles played by the autoimmune mechanism in the progression of myocarditis into dilated cardiomyopathy (DCM) using an animal model, we investigated whether autoimmune myocarditis might develop into DCM. METHODS: Experimental Balb/C mice (n = 20) were immunized with cardiac myosin with Freund's complete adjuvant at days 0, 7 and 30. The control Balb/C mice (n = 10) were immunized with Freund's complete adjuvant in the same mannere. Serum and myocardium samples were collected after the first immunization at days 15, 21 and 120. The anti-myosin antibody was examined by enzyme-linked immunosorbent assay and immunoblotting. RESULTS: Pathological findings demonstrated that there was myocardial necrosis or inflammatory infiltration during acute stages and fibrosis mainly in the late phase of experimental group, but the myocardial lesions were not found in the control group. Autoimmunity could induce myocarditis and DCM in the absence of viral infection. High titer anti-myosin IgG antibodies were found in the experimental group, but not in the control group. Furthermore, the anti-myosin heavy chain (200 KD) antibody was positive in 21 of 48 patients with DCM and viral myocarditis, but only 4 of 20 patients with coronary heart disease, including 1 case and 3 cases that reacted with heavy and light chains (27.5 KD), respectively. The antibodies were not detected in healthy donors. CONCLUSION: Cardiac myosin might be an autoantigen that provokes autoimmunity and leads to the transformation of myocarditis into DCM. Detection of anti-myosin heavy chain antibody might contribute to diagnosis for DCM and viral myocarditis.
|
|
| 15. |
- Weng, Jianping, et al.
(författare)
-
An automated fluorescent single strand conformation polymorphism technique for high throughput mutation screening
- 2001
-
Ingår i: Chinese Medical Journal. - 0366-6999. ; 114:11, s. 1147-1150
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: To develop a high throughput mutational detection method by multiple fluorescence-labeled polymerase chain reaction (PCR) products. METHODS: A total of 27 known mutations including 22 substitutions, 3 insertions (1, 2 and 7 bp) and 2 deletions (1 and 2 bp) in the hepatocyte nuclear factor (HNF)-4 alpha, glucokinase and HNF-1 alpha genes were tested. During nested PCR, amplified fragments were labeled with three fluorescent dyes. PCR products were visualized with an ABI-377 fluorescence sequencer using 5% glycerol or 10% sucrose in non-denaturing gel conditions. RESULTS: Twenty-five of 27 variants (93%) could be detected by combining 5% glycerol and 10% sucrose gel matrix conditions. Twenty-two of 27 (82%) and 18 of 27 (67%) variants were identified using 5% glycerol and 10% sucrose conditions, respectively. CONCLUSION: This fluorescence-based PCR single strand conformation polymorphism technique represents a simple, non-hazardous, time-saving and sensitive method for high throughput mutation detection.
|
|
| 16. |
- Zhang, Yong-Yuan, et al.
(författare)
-
Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction
- 1993
-
Ingår i: Chinese Medical Journal. - 0366-6999. ; 106:3, s. 171-174
-
Tidskriftsartikel (refereegranskat)abstract
- Antibodies to hepatitis C virus (anti-HCV) were determined in Chinese blood donors from the city of Wuhan by ELISA screening tests and confirmatory recombinant immunoblot assay (RIBA). 281 and 222 sera were sampled under similar conditions in 1989 and 1990, respectively. The first collection of sera was sent to Sweden in lyophilized form, the second directly as fresh, unfrozen sera. A high proportion (22%) of the lyophilized sera were positive in the screening assay but only 6 (2.10%) were positive by RIBA with antibodies against both the C100-3 and 5-1-1 peptides. HCV RNA could be detected by polymerase chain reaction (PCR) analysis in 3 of the 6 sera and in one reacting with C100-3 only. In the second material of fresh sera only 3 were positive in the screening anti-HCV ELISA, but none was RIBA or PCR positive. Thus, the overall prevalence of anti-HCV among the 503 Chinese blood donors as identified by RIBA was 1.2%, and that of HCV RNA by PCR was 0.8%. The confirmed antibody prevalence is higher than that reported in the western literature.
|
|
| 17. |
|
|
| 18. |
- Zhu, Yaobin, et al.
(författare)
-
A novel, minimally invasive rat model of normothermic cardiopulmonary bypass model without blood priming.
- 2014
-
Ingår i: Chinese Medical Journal. - 0366-6999. ; 127:8, s. 1541-1544
-
Tidskriftsartikel (refereegranskat)abstract
- Cardiopulmonary bypass (CPB) has been shown to be associated with systemic inflammatory response leading to postoperative organ dysfunction. Elucidating the underlying mechanisms and developing protective strategies for the pathophysiological consequences of CPB have been hampered due to the absence of a satisfactory recovery animal model. The purpose of this study was to establish a novel, minimally invasive rat model of normothermic CPB model without blood priming.
|
|
